Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut...
Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut its FQ3 and FY revenue forecast and halted shipments of it NanoKnife ablation device in the U.S. due to a software recall. It now sees Q3 sales between $50M - $53M versus estimates of $53M, and 2012 sales of around $215M - $219M compared to expectations of $221M.
From other sites
at Benzinga.com (Jan 8, 2015)
at MarketWatch.com (Jan 5, 2015)
at Nasdaq.com (Dec 1, 2014)
at MarketWatch.com (Apr 9, 2014)
at MarketWatch.com (Jan 9, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs